Rule 144 notice: CACI insider to sell 10,175 shares on NYSE

Rhea-AI Filing Summary

Form 144 notice from an insider at CACI International Inc. (CACI) discloses a proposed sale of 10,175 shares of common stock, with an aggregate market value of $5,014,476, planned for 09/15/2025 on the NYSE. The filing shows the shares were acquired on 10/01/2024 through equity vesting: 7,115 shares from MSU vesting and 3,060 shares from RSU vesting issued by CACI International Inc. No securities of the issuer were reported sold by the filer in the past three months. The notice includes the filer’s certification that they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Complete regulatory disclosure: The filer submitted a Rule 144 notice with acquisition dates, vesting types, broker, share counts, and aggregate value.
• Securities sourced from compensation vesting: The shares were acquired via MSU and RSU vesting (10/01/2024), indicating they originate from company awards rather than undisclosed transfers.

Negative

• Large proposed sale value: The aggregate market value of the planned sale is $5,014,476, which is a material dollar amount reported for insider sale activity.
• No explanation for sale provided: The filing contains no statement of purpose or trading plan beyond the standard attestation, so investor motivation is not disclosed.

Insights

Securities Analyst

TL;DR: Insider plans to sell vested equity totaling 10,175 shares valued at about $5.0M on 09/15/2025; transaction is disclosed under Rule 144.

The filing is a standard Rule 144 notice showing that the shares to be sold were acquired via company equity compensation (MSU and RSU vesting) on 10/01/2024. The sale is routed through UBS Financial Services and scheduled for the NYSE. Because the acquisition source is compensation-based vesting rather than open-market purchases or transfers, the filing indicates liquidity of vested equity rather than an additional capital-raising or third-party transfer. The document contains no statements about reasons for sale beyond the required representations, and no other recent sales were reported for the filer in the prior three months.

Corporate Governance Expert

TL;DR: The disclosure follows regulatory requirements; it confirms the insider's sale will be executed under standard brokerage arrangements.

The notice lists UBS Financial Services as the broker and provides required acquisition and payment details for each tranche of vested shares. The filer affirms no undisclosed material adverse information. The filing does not present governance concerns by itself, as it documents a planned sale of vested compensation and includes the mandatory attestation. No additional governance commentary or related-party transfer details are provided in the form.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	10175	5014476	21993445	09/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2024	MSU Vesting	CACI International Inc.			7115	09/15/2025	N/A
Common	10/01/2024	RSU Vesting	CACI International Inc.			3060	09/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for CACI (CACI) disclose?

The Form 144 discloses a proposed sale of 10,175 common shares valued at $5,014,476, scheduled for 09/15/2025 on the NYSE.

How were the shares being sold by the CACI filer acquired?

The shares were acquired on 10/01/2024 through equity compensation: 7,115 shares from MSU vesting and 3,060 shares from RSU vesting.

Which broker is handling the proposed sale in the Form 144?

The filing lists UBS Financial Services Inc. (1000 Harbor Blvd, Weehawken, NJ) as the broker for the transaction.

Did the filer report any securities sold in the past three months?

No. The form states Nothing to Report for securities sold during the past three months by the filer.

Does the Form 144 include any disclosure of undisclosed material information?

The filer signs the required representation stating they do not know of any material adverse information about the issuer that has not been publicly disclosed.